Literature DB >> 30995958

In Reply.

Andreas Koch.   

Abstract

Year:  2019        PMID： 30995958      PMCID： PMC6482371          DOI： 10.3238/arztebl.2019.0175c

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  5 in total

Review 1.  Risk of extrapyramidal side effects comparing continuous vs. bolus intravenous metoclopramide administration: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Iván Cavero-Redondo; Celia Álvarez-Bueno; Diana P Pozuelo-Carrascosa; Ana Díez-Fernández; Blanca Notario-Pacheco
Journal:  J Clin Nurs       Date:  2015-09-15       Impact factor: 3.036

Review 2.  The Neurophysiology and Treatment of Motion Sickness.

Authors:  Andreas Koch; Ingolf Cascorbi; Martin Westhofen; Manuel Dafotakis; Sebastian Klapa; Johann Peter Kuhtz-Buschbeck
Journal:  Dtsch Arztebl Int       Date:  2018-10-12       Impact factor: 5.594

Review 3.  Neuronal mechanisms and the treatment of motion sickness.

Authors:  F Schmäl
Journal:  Pharmacology       Date:  2013-04-20       Impact factor: 2.547

4.  Motion sickness adaptation: a neural mismatch model.

Authors:  J T Reason
Journal:  J R Soc Med       Date:  1978-11       Impact factor: 18.000

Review 5.  Moving in a Moving World: A Review on Vestibular Motion Sickness.

Authors:  Giovanni Bertolini; Dominik Straumann
Journal:  Front Neurol       Date:  2016-02-15       Impact factor: 4.003
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.